Covidien plc to Report Fourth-Quarter Results on November 9, 2012

Covidien plc to Report Fourth-Quarter Results on November 9, 2012

DUBLIN--(BUSINESS WIRE)-- Covidien plc (NYSE: COV) will report fourth-quarter results on November 9, 2012, before trading begins. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:

  • At Covidien's website:
  • By telephone: For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 800-295-4740. For participants outside the U.S., the dial-in number is 617-614-3925. The access code for all callers is 60514263.
  • Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. on November 9, 2012, and ending at 5:00 p.m. on November 16, 2012. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 67017254.


Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 43,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit to learn more about our business.

Covidien plc
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
Bruce Farmer, 508-452-4372
Vice President
Public Relations
Todd Carpenter, 508-452-4363
Investor Relations

KEYWORDS:   Europe  Ireland


Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.